Qureight Stock

Qureight is an imaging analytics company that develops artificial intelligence software, imaging technologies, and data science platforms that support clinical trials for biopharmaceutical companies and research organizations. The company provides cloud-based tools for medical image management, imaging data curation, central image review, and quantitative analysis of clinical imaging and healthcare data, with an emphasis on lung and heart diseases. Its platform combines deep learning, imaging biomarkers, clinical data integration, and analytics to help evaluate disease progression, treatment response, patient stratification, and clinical trial endpoints. Qureight also offers imaging contract research services, synthetic control arm development, data quality management, and scientific consulting to support drug development and clinical research programs. The company's technology is designed to streamline imaging workflows, improve the analysis of complex clinical datasets, and generate evidence that supports decision-making throughout the clinical trial process.